Central blood pressure reflects left ventricular load, while brachial blood pressure reflects arterial damage

2014 ◽  
Vol 23 (6) ◽  
pp. 356-362 ◽  
Author(s):  
Sumiyo Yamashita ◽  
Yasuaki Dohi ◽  
Hiroyuki Takase ◽  
Tomonori Sugiura ◽  
Nobuyuki Ohte
2017 ◽  
Vol 56 (6) ◽  
pp. 587-596 ◽  
Author(s):  
Masaki Ryuzaki ◽  
Satoshi Morimoto ◽  
Michita Niiyama ◽  
Yasufumi Seki ◽  
Naohiro Yoshida ◽  
...  

VASA ◽  
2016 ◽  
Vol 45 (6) ◽  
pp. 451-460 ◽  
Author(s):  
Michael Kostapanos ◽  
Carmel M. McEniery ◽  
Ian B. Wilkinson

Abstract. Vital organs are exposed to the central rather than the brachial blood pressure. To date, central blood pressure can be assessed noninvasively through the use of several devices. In this review, we critically discuss the clinical relevance of central blood pressure assessment. Considerable evidence suggests that central blood pressure is a better predictor of end-organ damage than brachial blood pressure. However, there is still uncertainty concerning the value of central pressure for predicting cardiovascular outcomes, as the existing studies are underpowered to address this issue. A full synthesis of the available data is needed in this regard. Among the different antihypertensive drug classes, beta-blockers appear to lower central blood pressure less than brachial blood pressure. This difference may, at least in part, explain the reduced efficacy of beta-blockers in the prevention of cardiovascular outcomes compared with the other antihypertensive drug classes, which may lower central and brachial blood pressure to a similar extent. Nevertheless, this differential effect might not be relevant to the newer beta-blockers with vasodilating properties, including nebivolol, celliprolol and carvedilol. However, whether a preferential reduction of central blood pressure results in better outcomes should be further assessed by appropriately powered clinical trials. Other emerging challenges include the assessment of the potential predictive value of central blood pressure variability and the development of new antihypertensive medications based on central blood pressure rather than brachial blood pressure.


2021 ◽  
Vol 27 (1) ◽  
Author(s):  
Ki-Hyun Jeon ◽  
Hack-Lyoung Kim ◽  
Woo-Hyun Lim ◽  
Jae-Bin Seo ◽  
Sang-Hyun Kim ◽  
...  

Abstract Background It is not well-known which components of central blood pressure (CBP) are more influential to target organ damage (TOD). This study aimed to determine the relationship between CBP measurements and various types of TOD in high-risk patients. Methods A total of 148 patients who had documented atherosclerotic cardiovascular disease or its multiple risk factors were prospectively enrolled. CBP was measured by using applanation tonometry of the radial artery. The following nine TOD parameters were evaluated: left ventricular mass index, relative wall thickness, septal e′ velocity, septal E/e′, brachial-ankle pulse wave velocity, ankle-brachial index, estimated glomerular filtration rate, urine protein and obstructive coronary artery disease. Results The mean age of the study population was 67.1 ± 9.0 years and 108 (73 %) were male. Among four CBP measurements (systolic, diastolic, mean, and pulse pressures), central pulse pressure (CPP) was associated with the largest number of TOD parameters. As CPP increased, the number of TOD increased (P = 0.010), but this association was not observed in other CBP measurements (P > 0.05 for each). Conclusions CPP had a stronger correlation with TOD than other CBP measurements. Non-invasive CPP could be a useful indicator for predicting TOD in patients at high coronary risk.


2017 ◽  
Vol 20 (C) ◽  
pp. 67
Author(s):  
Stefano Omboni ◽  
Igor N. Posokhov ◽  
Gianfranco Parati ◽  
Vitaliy S. Barkan ◽  
Ernesto Cardona Muñoz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document